A Lipoglycopeptide Antibiotic for Gram-Positive Biofilm-Related Infections

Scientists developed a preclinical glycopeptide antibiotic, MCC5145, that had excellent potency against hundreds of isolates of methicillin-resistant S. aureus and other Gram-positive bacteria, with a greater than 1000-fold margin over mammalian cell cytotoxicity values.